- Previous Close
4.2500 - Open
4.1500 - Bid --
- Ask --
- Day's Range
4.1000 - 4.2100 - 52 Week Range
4.1000 - 7.2400 - Volume
14,173 - Avg. Volume
111,912 - Market Cap (intraday)
187.064M - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
-- - EPS (TTM)
-1.0900 - Earnings Date Apr 1, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.15
Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
www.onwd.comRecent News: ONWD.BR
View MorePerformance Overview: ONWD.BR
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ONWD.BR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ONWD.BR
View MoreValuation Measures
Market Cap
184.83M
Enterprise Value
170.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
10.07
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-41.83%
Return on Equity (ttm)
-133.61%
Revenue (ttm)
-188k
Net Income Avi to Common (ttm)
-35.15M
Diluted EPS (ttm)
-1.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
32.05M
Total Debt/Equity (mrq)
94.37%
Levered Free Cash Flow (ttm)
-17.19M